{"id":21004,"date":"2014-05-02T10:18:29","date_gmt":"2014-05-02T14:18:29","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=21004"},"modified":"2014-05-02T10:18:29","modified_gmt":"2014-05-02T14:18:29","slug":"avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004","title":{"rendered":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0One of the leading players in the pharmaceutical business,<b> <\/b><strong>Avanir Pharmaceuticals Inc (NASDAQ:AVNR) <\/strong>operates towards development\u00a0 of therapeutic products in the field of treatment of CNS disorders. Recently many actions have taken place in the Avanir&#8217;s front including series of announcements and lawsuits. The company is marking up towards development of a robust strategy for gaining desired results in the coming quarters.<\/p>\n<p style=\"text-align: justify;\"><b>Gearing up for Conferences<\/b><\/p>\n<p style=\"text-align: justify;\"><b><\/b>Recently Avanir has announced that the company is gearing up for participating in two of the prime conferences in the month of May. The company has announced the details of the same through a press release. Avanir has declared that the company will participate in \u2013 Firstly, Deutsche Bank 39<sup>th<\/sup> Annual Health Care Conference to b held on May 8, 2014 and Bank of America\u00a0 Merrill Lynch 2014 Health Care conference on May 13, 2014. The company will present a live webcast for 30 days that can be accessed via official website of the company.<\/p>\n<p style=\"text-align: justify;\"><b>Inclination of Lawsuits In Favor Of Avanir<\/b><\/p>\n<p style=\"text-align: justify;\">Recently Avanir has announced that the U.S. District Court has ruled in favor of Avanir and against <strong>Impax Laboratories Inc (NASDAQ:IPXL)<\/strong><b> <\/b>and Par Pharmaceuticals, Inc. related to patent infringement. The two contesting companies had filed ANDAs (Abbreviated New Drug Application) to obtain the generic visions of Avanir\u2019s Nuedexta the rejection in favor of Avanir\u2019s Nuedexta has helped in gaining exclusivity to the Avanir\u2019s business. Avanir is looking forward towards expanding Nuedexta\u2019s label in the U.S. and across the globe.<\/p>\n<p style=\"text-align: justify;\"><b>Announcement of dates for 2Q2014 results<\/b><\/p>\n<p style=\"text-align: justify;\">Avanir recently announced the dates for the announcement of financial results of 2Q22014 results for the quarter ending on March 31, 2014. Avanir Pharmaceuticals Inc (NASDAQ:AVNR)<b>\u00a0<\/b>\u00a0is scheduled to declare the result on May 6, 2014 after the close of market. Avanir has also declared to hold a conference call and audio webcast of the results at 1:30 pm on the same day. Further, Avanir will also hold a replay of the webcast on the official website for 30 days.<b>\u00a0<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0One of the leading players in the pharmaceutical business, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) operates towards development\u00a0 of therapeutic products in the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":21008,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2502,6295,2503,6296],"stock_ticker":[],"class_list":["post-21004","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-avanir-pharmaceuticals-inc-nasdaqavnr","tag-impax-laboratories-inc-nasdaqipxl","tag-nasdaqavnr","tag-nasdaqipxl","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0One of the leading players in the pharmaceutical business, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) operates towards development\u00a0 of therapeutic products in the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-02T14:18:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"468\" \/>\n\t<meta property=\"og:image:height\" content=\"101\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front\",\"datePublished\":\"2014-05-02T14:18:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\"},\"wordCount\":345,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg\",\"keywords\":[\"Avanir Pharmaceuticals Inc. (NASDAQ:AVNR)\",\"Impax Laboratories Inc (NASDAQ:IPXL)\",\"NASDAQ:AVNR\",\"NASDAQ:IPXL\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\",\"name\":\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg\",\"datePublished\":\"2014-05-02T14:18:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg\",\"width\":468,\"height\":101},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004","og_locale":"en_US","og_type":"article","og_title":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front - Wall Street PR","og_description":"Boston, MA 05\/02\/2014 (wallstreetpr) &#8211;\u00a0One of the leading players in the pharmaceutical business, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) operates towards development\u00a0 of therapeutic products in the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-05-02T14:18:29+00:00","og_image":[{"width":468,"height":101,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front","datePublished":"2014-05-02T14:18:29+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004"},"wordCount":345,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg","keywords":["Avanir Pharmaceuticals Inc. (NASDAQ:AVNR)","Impax Laboratories Inc (NASDAQ:IPXL)","NASDAQ:AVNR","NASDAQ:IPXL"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004","url":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004","name":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg","datePublished":"2014-05-02T14:18:29+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/images-3.jpg","width":468,"height":101},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/avanir-pharmaceuticals-inc-nasdaqavnr-lot-of-action-at-the-avanir-front-21004#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Avanir Pharmaceuticals Inc (NASDAQ:AVNR): Lot Of Action At The Avanir Front"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/21004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=21004"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/21004\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/21008"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=21004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=21004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=21004"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=21004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}